Transaction #38006 · Form 4 · 0001193125-26-448845

MakeMyTrip Ltd · Exercise / conversion · Ordinary Shares

MakeMyTrip Ltd · Transacted November 4, 2026 · Filed November 5, 2026

Original SEC filing ↗

What does this filing report?

An SEC Form 4 filing for MakeMyTrip Ltd records an exercise / conversion involving Ordinary Shares on November 4, 2026. The reported quantity was 10,000. The filing date is November 5, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Transaction details

Company CIK
0001495153
Security type
Non-derivative
Acquisition type
Exercise / conversion · Code M
Quantity acquired
10,000
Reported price
0.0005
Reference value
5
Currency
Currency not specified
Ownership
Direct
Holdings after transaction
10,000
Ownership description
Not reported
SEC acceptance time
Nov 5, 2026, 9:35 AM EST
10b5-1 indication
Not indicated

Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.

Reporting owners

These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.

Company listings

MMYT · Nasdaq · linked security

The linked listing is identified separately from other current company listings.

Filing footnotes & remarks

F1
The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions at prices ranging from $45.20 to $45.45. The reporting person undertakes to provide the Company, any shareholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the range set forth in this footnote.
F2
The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions at prices ranging from $50.01 to $50.37. The reporting person undertakes to provide the Company, any shareholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the range set forth in this footnote.
F3
Following the transaction dated November 3, 2026, 1,384,185 Restricted Stock Units (RSUs) are vested, with expiration dates ranging from March 31, 2028 to June 30, 2031 unless extended at the sole discretion of the Company. In addition, 29,478 RSUs remain unvested and are scheduled to vest between April 1, 2027 to April 1, 2030, with expiration dates ranging from March 31, 2031 to March 31, 2034, subject to extension at the sole discretion of the Company, and include 14,739 performance-based RSUs relating to 14,739 ordinary shares subject to the achievement of certain performance-based vesting conditions.
F4
Following the transaction dated November 4, 2026, 1,374,185 RSUs are vested, with expiration dates ranging from March 31, 2028 to June 30, 2031 unless extended at the sole discretion of the Company. In addition, 29,478 RSUs remain unvested and are scheduled to vest between April 1, 2027 to April 1, 2030, with expiration dates ranging from March 31, 2031 to March 31, 2034, subject to extension at the sole discretion of the Company, and include 14,739 performance-based RSUs relating to 14,739 Ordinary Shares subject to the achievement of certain performance-based vesting conditions.

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.

This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.